Table 6.
Predictor | P | Hazard Ratio | 95% Confidence Interval |
---|---|---|---|
Age | <0.001 | 3.76 | 1.82–7.78 |
Sex | 0.33 | 0.69 | 0.33–1.45 |
ANCA specificity in ELISA | 0.51 | 1.47 | 0.46–4.68 |
Initial serum creatinine (μmol/L) | 0.001 | ||
first tertile (≤170) | 0.0001 | 0.08 | 0.02–0.30 |
second tertile (171–447) | 0.24 | 0.64 | 0.31–1.35 |
third tertile (>447) | Reference group | ||
Oral cyclophosphamide/pulse cyclophosphamide | 0.98 | 1.01 | 0.50–2.04 |
Plasma exchange | 0.90 | 0.87 | 0.11–7.13 |
Intravenous methylprednisolone pulse therapy | 0.02 | 0.32 | 0.13–0.81 |
HLA-DPB1*0402 | 0.01 | 2.52 | 1.21–5.28 |